Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Bill DeVaul

Bill DeVaul

individual
Ecosystem influencer

About

Bill DeVaul is a biotechnology legal executive serving as Chief Legal Officer of Cambrian Bio, a clinical-stage drug development company focused on therapeutics for age-related metabolic decline. He previously served as General Counsel, Chief Compliance Officer, and Corporate Secretary at Morphic Holding, and earlier held senior legal and intellectual-property roles at Evelo Biosciences and Cubist Pharmaceuticals. His background centers on biotech legal strategy, IPOs, financings, licensing, M&A, compliance, and intellectual property.

Areas of interest

longevitybiotechdrug developmentintellectual propertycorporate governancecompliancelicensingmergers and acquisitions